| Uniprot ID: | |
| Secondary ID: | |
| Symbol: | miR-214 |
| Other Name: | |
| Class: | Epigenetics |
| Type: | anti-fibrotic |
| Molecular Function: |
| Category I | Category II | Category III |
|---|---|---|
| Intracellular | Epigenetics | microRNA |
Reference Record 1
| PubMed ID | 28729638 | Compound ID | |
| CAS | Name | ||
| Model | vitro,human,rat | Fibrosis Disease | Bladder fibrosis |
| Process I | |||
| Process II | EMT | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting Mfn2 | ||
Reference Record 2
| PubMed ID | 27823969 | Compound ID | |
| CAS | Name | ||
| Model | vitro,mice | Fibrosis Disease | Cardiac fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting EZH1 and EZH2 | ||
Reference Record 3
| PubMed ID | 26692091 | Compound ID | |
| CAS | Name | ||
| Model | vitro,rat | Fibrosis Disease | Cardiac fibrosis |
| Process I | |||
| Process II | fibroblasts proliferation | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting Mfn2 and ERK1/2 signaling pathway | ||
Reference Record 4
| PubMed ID | 26692091 | Compound ID | |
| CAS | Name | ||
| Model | vitro,rat | Fibrosis Disease | Cardiac fibrosis |
| Process I | |||
| Process II | fibroblasts proliferation | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting Mfn2 and ERK1/2 signaling pathway | ||